Rutvi Doshi

Rutvi Doshi currently serves as the Global Medical Lead for Corneal Health at Glaukos Corporation, where the focus is on the medical launch strategy for Epioxa, a therapy for keratoconus, and building strategic partnerships with KOLs and societies. Additionally, Rutvi is a Medical Strategy Consultant, advising early-stage biotech companies on medical strategy within ophthalmology and rare diseases. Previously, Rutvi held roles including Medical Director at Tarsus Pharmaceuticals, Sales Director at Dompé, and Director of Optometry at the University of Chicago - The Pritzker School of Medicine. Educational qualifications include a residency in Cornea and Contact Lens and a Doctor of Optometry degree from the New England College of Optometry.